Navigoe Wealth Management’s Bristol-Myers Squibb Rights CELG.RT Stock Holding History

Navigoe Wealth Management’s Portfolio CELG.RT Stock Details CELG.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+36	New	+$4	﹤0.01%	550

Other funds holding CELG.RT

TCA

Transcend Capital Advisors Madison, New Jersey $1.48B AUM 25.55% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PCA

Purkiss Capital Advisors Ridgefield, Connecticut $263M AUM 29.59% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return

Oakworth Capital Birmingham, Alabama $2.1B AUM 24.07% 1-Year Est. Return

Navigoe Wealth Management's CELG.RT Position: Q2 2026 in Review

Navigoe Wealth Management opened a new position in Bristol-Myers Squibb Rights (CELG.RT) in Q2 2026: 36 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #550 among its holdings.

15 funds tracked by Wall St. Rank hold CELG.RT as of Q2 2026.

Navigoe Wealth Management held 36 shares of Bristol-Myers Squibb Rights worth $0 as of Q2 2026.
Bristol-Myers Squibb Rights was a new Navigoe Wealth Management position in Q2 2026.
Bristol-Myers Squibb Rights made up ﹤0.01% of Navigoe Wealth Management's portfolio in Q2 2026, its #550 holding.
15 funds tracked by Wall St. Rank held Bristol-Myers Squibb Rights as of Q2 2026.

Based on Navigoe Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.